ARCH Venture Fund XII, L.P., 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 281,210 shares at $11.37 ($3.1M) on 2023-11-10, disclosed to the SEC on 2023-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.78 | 69,127 | $745K | 24.1% |
| 2 | $10.78 | 69,127 | $745K | 24.1% |
| 3 | $11.79 | 23,124 | $273K | 8.8% |
| 4 | $11.79 | 23,124 | $273K | 8.8% |
| 5 | $10.53 | 31,079 | $327K | 10.6% |
| 6 | $10.53 | 31,079 |
| $327K |
| 10.6% |
| 7 | $11.37 | 11,844 | $135K | 4.4% |
| 8 | $11.37 | 11,844 | $135K | 4.4% |
| 9 | $11.75 | 5,431 | $64K | 2.1% |
| 10 | $11.75 | 5,431 | $64K | 2.1% |
| Total | $10.98 avg | 281,210 | $3.1M | 100% |
| Filing → |